ScanSource director granted 3,234 shares

A ScanSource director received an equity award of 3,234 common shares, increasing his direct holdings to 28,027 shares.

Rhea-AI Filing Summary

SCANSOURCE, INC. (SCSC) reported that director Charles Alexander Mathis acquired 3,234 shares of common stock on September 1, 2026 through a grant, award, or other acquisition at a reported price of $0.00 per share, reflecting non-cash equity compensation. Following this award, he directly holds 28,027 shares of ScanSource common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 3,234 shares

Grant/Award 1 txn

Insider Mathis Charles Alexander

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,234	$0.00	$0.00

Holdings After Transaction: Common Stock — 28,027 shares (Direct)

Key Figures

Shares acquired: 3,234 shares Price per share: $0.00 per share Shares owned after transaction: 28,027 shares

3 metrics

Shares acquired 3,234 shares Equity grant to director on September 1, 2026

Price per share $0.00 per share Reported grant price for the 3,234-share award

Shares owned after transaction 28,027 shares Director’s direct holdings following the award

Key Terms

Grant, award, or other acquisition, Common Stock, Rule 10b5-1

3 terms

Grant, award, or other acquisition financial

"classified as a grant, award, or other acquisition of common stock"

Common Stock financial

"3,234 shares of Common Stock on September 1, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SCSC disclose for Charles Alexander Mathis?

The company disclosed that director Charles Alexander Mathis received an award of 3,234 shares of Common Stock on September 1, 2026, recorded as a grant, award, or other acquisition.

How many SCSC shares does the director hold after this Form 4 transaction?

After the reported award, Charles Alexander Mathis directly holds 28,027 shares of ScanSource, Inc. common stock, according to the Form 4 filing.

What was the price per share for the SCSC stock awarded to the director?

The Form 4 reports a transaction price of $0.00 per share for the 3,234-share grant, indicating it was received as non-cash equity compensation rather than purchased in the market.

Was the SCSC insider transaction made under a Rule 10b5-1 trading plan?

No. The filing shows the Rule 10b5-1 checkbox as not affirmed, indicating that this equity award was not reported as being made under a Rule 10b5-1 trading plan.

What type of security did the SCSC director acquire in this Form 4?

The transaction involves Common Stock of ScanSource, Inc. The Form 4 classifies the transaction as a non-derivative grant, award, or other acquisition of 3,234 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:02 PM Accepted by SEC EDGAR 09/03/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mathis Charles Alexander

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SOUTH CAROLINA 29615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		3,234	A	$0.00	28,027	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	J. Creighton Lynes, attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)